Animal Vaccines Market Size To Reach $32.4 Billion By 2033

Animal Vaccines Market Growth & Trends

The global animal vaccines market size is estimated to reach USD 32.4 billion by 2033, expanding at a CAGR of 10.5% from 2026 to 2033, according to a new report by Grand View Research, Inc. The growing incidence of food-borne zoonotic diseases and increasing animal husbandry are boosting the demand for vaccines. Certain transmissible diseases such as bird flu and tuberculosis in invertebrate animals can be transferred directly or indirectly to humans. If consumers eat worms via undercooked fish, they can get contaminated with anisakiasis, a human zoonotic infection caused by some species of nematodes.

The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Moreover, rising pet ownership and increasing awareness regarding the health of companion animals are propelling the market growth. Moreover, the increasing number of R&D investments initiated by the companies is one of the key growth factors. Competition in the market is expected to be high during the forecast period. The market is highly fragmented owing to the presence of several small and large players. This results in high competition among small players to sustain their position in the market.

Moreover, companies are increasingly adopting strategies, such as mergers & acquisitions, geographic expansion, and the launch of new products, to grow in the market. For instance, in December 2020, Elanco acquired exclusive global rights from Kindred Biosciences to its monoclonal antibody for Canine Parvovirus (CPV) called KIND-030. This strengthened the company’s overall vaccine and therapeutics portfolios. Moreover, in September 2020, Ceva enhanced its production capacity at its French facility for bacterial autogenous vaccines. This is expected to support its growth strategy.

 Request a free sample copy or view report summary: Animal Vaccines Market Report

Animal Vaccines Market Report Highlights

• The attenuated live vaccines segment dominated the market and accounted for a revenue share of over 34.6% in 2025.

• The livestock segment dominated the market with the highest revenue share in 2025. This can be attributed to factors such as the rising livestock population, supportive government initiatives, and the outbreak of diseases among cattle and sheep.

• Hospital/clinic pharmacy held the dominant share of the market in 2025. These facilities are often at the forefront of adopting new technologies.

• The injectable segment held the largest share in 2025. The segment’s growth is influenced by its high efficacy, rapid immune response, and precise dosage delivery across livestock and companion animals.

• North America dominated the market and accounted for a revenue share of over 36% in 2025. The region is expected to remain dominant throughout the forecast period.

Animal Vaccines Market Segmentation

Grand View Research has segmented the global animal vaccines market based on product, animal, route of administration, distribution channel, and region:

Animal Vaccines Product Outlook (Revenue, USD Million, 2021 - 2033)

• Attenuated Live Vaccines

• Inactivated Vaccines

• Subunit Vaccines

• DNA & RNA Vaccines

• Recombinant Vaccines

• Autologous Vaccines

• Other Vaccines

Animal Vaccines Animal Outlook (Revenue, USD Million, 2021 - 2033)

• Livestock

  • Poultry

  • Aqua

  • Ruminants

  • Swine

• Companion

  • Canine

  • Feline

  • Equine

  • Others

Animal Vaccines Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

• Injectable

  • Subcutaneous

  • Intramuscular

  • Intradermal

  • Intraperitoneal

• Oral

• Other Routes

Animal Vaccines Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Retail

• E-Commerce

• Hospital/ Clinic Pharmacy

• Veterinary Supply Distributors

• Other Channels

Animal Vaccines Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players of Animal Vaccines Market

• Zoetis

• Merck & Co., Inc.

• Boehringer Ingelheim Animal Health

• Elanco

• Virbac

• Phibro Animal Health Corporation

• Calier

• Ceva

• Bimeda Biologicals

• Neogen Corporation